Issue 2, 2013

Synthesis of hetero annulated carbazoles: exploration of in vitro cytotoxicity and molecular docking studies

Abstract

The newly synthesized hetero annulated carbazoles were prepared in good yields and structurally characterized by all spectral means. The in vitro cytotoxicity was evaluated for all the synthesized compounds by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay against HeLa and MCF 7 and compared with the standard drug ellipticine. Compound 5b outperformed the standard drug ellipticine. All the compounds showed moderate to potent activity against the cell lines. The preliminary structure–activity relationships were carried out. In order to understand the nature of interactions of these molecules we carried out molecular docking studies using the protein kinase CK2 inhibitors. The docking results provided some useful information for the future design of more potent inhibitors.

Graphical abstract: Synthesis of hetero annulated carbazoles: exploration of in vitro cytotoxicity and molecular docking studies

Supplementary files

Article information

Article type
Concise Article
Submitted
06 Nov 2012
Accepted
14 Dec 2012
First published
17 Jan 2013

Med. Chem. Commun., 2013,4, 450-455

Synthesis of hetero annulated carbazoles: exploration of in vitro cytotoxicity and molecular docking studies

T. Indumathi, A. Muthusankar, P. Shanmughavel and K. J. R. Prasad, Med. Chem. Commun., 2013, 4, 450 DOI: 10.1039/C2MD20335A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements